Skip to main content
Erschienen in: Clinical Research in Cardiology 4/2024

Open Access 03.05.2023 | Original Paper

A machine-learning-based prediction of non-home discharge among acute heart failure patients

verfasst von: Akira Okada, Hidehiro Kaneko, Masaaki Konishi, Kentaro Kamiya, Tadafumi Sugimoto, Satoshi Matsuoka, Isao Yokota, Yuta Suzuki, Satoko Yamaguchi, Hidetaka Itoh, Katsuhito Fujiu, Nobuaki Michihata, Taisuke Jo, Hiroki Matsui, Kiyohide Fushimi, Norifumi Takeda, Hiroyuki Morita, Hideo Yasunaga, Issei Komuro

Erschienen in: Clinical Research in Cardiology | Ausgabe 4/2024

Abstract

Background

Scarce data on factors related to discharge disposition in patients hospitalized for acute heart failure (AHF) were available, and we sought to develop a parsimonious and simple predictive model for non-home discharge via machine learning.

Methods

This observational cohort study using a Japanese national database included 128,068 patients admitted from home for AHF between April 2014 and March 2018. The candidate predictors for non-home discharge were patient demographics, comorbidities, and treatment performed within 2 days after hospital admission. We used 80% of the population to develop a model using all 26 candidate variables and using the variable selected by 1 standard-error rule of Lasso regression, which enhances interpretability, and 20% to validate the predictive ability.

Results

We analyzed 128,068 patients, and 22,330 patients were not discharged to home; 7,879 underwent in-hospital death and 14,451 were transferred to other facilities. The machine-learning-based model consisted of 11 predictors, showing a discrimination ability comparable to that using all the 26 variables (c-statistic: 0.760 [95% confidence interval, 0.752–0.767] vs. 0.761 [95% confidence interval, 0.753–0.769]). The common 1SE-selected variables identified throughout all analyses were low scores in activities of daily living, advanced age, absence of hypertension, impaired consciousness, failure to initiate enteral alimentation within 2 days and low body weight.

Conclusions

The developed machine learning model using 11 predictors had a good predictive ability to identify patients at high risk for non-home discharge. Our findings would contribute to the effective care coordination in this era when HF is rapidly increasing in prevalence.
Hinweise

Supplementary Information

The online version contains supplementary material available at https://​doi.​org/​10.​1007/​s00392-023-02209-0.

Introduction

The number of patients with heart failure (HF) is increasing worldwide. Currently, there estimated to be 64 million HF patients globally [1]. It is considered a critical epidemiological condition globally [24], and a serious issue in Asia as well [57]. Due to the super-aging society, the prevalence of HF is rapidly increasing in Japan. It is estimated that there are approximately 1 million HF patients in Japan, and the number of patients with HF is predicted to increase continuously, reaching 1.3 million by 2030 [8]. The Japanese Circulation Society conducted the Japanese Registry Of All cardiac and vascular Diseases (JROAD) to collect the data from almost all teaching hospitals with cardiovascular beds. According to JROAD, the annual number of patients with acute HF (AHF) hospitalization increased by 22% from 212,793 in 2012 to 260,157 in 2016 (while that of acute myocardial infarction increased by 6% during the same period) [9]. To overcome this critical condition due to increasing AHF, preparing the optimal medical care system which enables seamless treatments (acute- and chronic-phase) for patients with AHF is essential [10]. From this point of view, it is essential to integrate the comprehensive care system for HF patients and to develop a medical coordination system in a community. For this end, it would be clinically valuable to predict the discharge disposition of hospitalized patients owing to AHF. Generally, the main goal of health care providers is to discharge hospitalized AHF patients home. However, some patients have difficulty being discharged home, and we must find a suitable facility to which each patient would be transferred accordingly in a community. This process is burdensome for not only health care providers but also patients and their families. If discharge disposition can be predicted in the early stages of hospitalization, we will be able to simultaneously proceed with acute care for patients with AHF and the process of medical coordination in a community, thereby efficient acute management, smooth healthcare coordination, shorter hospital stays, and ultimately, lower inpatient care costs could be achieved. Nevertheless, clinical evidence on discharge disposition and its determinants has been scarce. Here, we aimed to identify determinants of discharge to other facilities (not to home) using a nationwide inpatient database. We believe that it is important to overview the state of management for AHF focusing on discharge disposition using large-scale data at this timing when the critical epidemiological condition owing to increase in the number of AHF patients is rapidly approaching worldwide.

Methods

Data source

This study is a retrospective cohort study using data extracted from the Japanese Diagnosis Procedure Combination (DPC) database, a Japanese national inpatient database. The details of the DPC database have been explained previously [11, 12]. The DPC database has detailed information on admitted patients. The following data on patient information were available: age; sex; body height and weight; activities of daily living based on the Barthel Index; consciousness level at time of admission; admission status (scheduled/unscheduled and use of ambulance service); several diagnosis names (main diagnosis, diagnosis requiring admission, and comorbidities existing at the time of admission recorded as International Classification of Diseases, 10th Revision (ICD-10) codes and text data in Japanese; daily procedures performed or daily drugs administered during hospitalization. The DPC database has had information as to the origin of patients among those discharged since April 2014, i.e., whether the patient was transferred from another hospital or nursing facility or not.
We had the study protocol on this study approved by the institutional review board of the University of Tokyo [approval number: 3501-(3)]. Because we used data that had been anonymized, the necessity for informed consent was waived.

Study design and population

Using the DPC database, we extracted data on patients undergoing an unscheduled admission, not transferred from nursey facilities or other hospitals, for the treatment of AHF of New York Heart Association (NYHA) classification ≥ II on record from April 1, 2014 to March 31, 2018. The ICD-10 codes used to identify AHF were I50.0, I50.1, and I50.9, and these diagnoses were required to be recorded as a diagnosis requiring admission and the main diagnosis of admission. The exclusion criteria were as follows: missing information on discharge disposition; age < 20 years; length of hospital stay < 3 days; and patients with missing data on Barthel index or body mass index (BMI).

Variables and candidate predictors

We used the following data from the extracted dataset: age, sex, BMI, smoking status, Japan Coma Scale score at admission, Barthel Index, the severity of AHF at admission, comorbidities at admission, use of ambulance, and several kinds of procedures performed within 2 days of hospital admission.
Age, BMI, and Barthel index were treated as continuous variables. Consciousness level at admission was dichotomized into two groups, based on whether the patient had impaired consciousness or not. The severity of HF was based on NYHA classification (Class II-IV) as categorical variables. We used comorbidities present at admission based on the ICD-10 codes as follows: anemia (ICD-10 codes starting with D46, D5, D60-64); hypertension (ICD-10 codes starting with I10-13, I15); ischemic heart disease (ICD-10 codes starting with I21-24); diabetes (ICD-10 codes starting with E10-14); chronic pulmonary disease (ICD-10 codes starting with I27, J40-45, J60–J62, J64-67, and J70); chronic liver disease (ICD-10 codes starting with B18, K70-74, and K76); kidney failure (ICD-10 code starting with N18 or N19); cancer (ICD-10 codes starting with C or D0); and osteoporosis (ICD-10 code starting with M800-805, M808, M809, M810-816, M818, M819, M820, M821, or M828). We also considered cardiac complications present at admission based on the ICD-10 codes as follows: shock status (ICD-10 codes starting with R57); ventricular tachycardia/fibrillation (ICD-10 codes starting with I490); and dilated cardiomyopathy (ICD-10 codes starting with I42). Among diagnoses present at admission except AHF, we also used the weighted total of comorbidities using Charlson comorbidity index as defined [13]; therefore, the value of 0 can exist. We prepared a binary variable showing whether the patient had hospitalized within the prior 30 days. Use of following drugs or procedures within 2 days were also used as binary variables: loop diuretics; vasopressors; intensive care unit; enteral alimentation initiation; kidney replacement therapy (intermittent dialysis or continuous hemodiafiltration) and intensive cardiopulmonary support (tracheal intubation, intra-aortic balloon pumping, or extracorporeal membrane oxygenation).
Candidate predictive factors were selected among those used on previous studies [11, 12, 14] and variables that are clinically relevant and can be obtained in the DPC database. Specifically, the candidate risk factors included patient age; sex; BMI; Barthel index on admission; consciousness level on admission; the severity of HF based on NYHA criteria; comorbidities present on admission such as hypertension, ischemic heart disease, diabetes mellitus, pulmonary disease, liver disease, dilated cardiomyopathy, kidney failure or kidney replacement therapy, shock status or ventricular tachycardia/fibrillation, osteoporosis, and anemia or receipt of transfusion; Charlson comorbidity index; day of the week at admission; procedures generally reflecting the severity of AHF. We also included the following variables that were clinically effective in treating patients: whether to initiate enteral alimentation, rehabilitation within 2 days of admission. Furthermore, we added the following binary variables associated with severity or comorbidity: whether to undergo use of intensive cardiopulmonary support, loop diuretics, intravenous vasopressors, or intensive care unit within 2 days of admission.

Study outcomes and variables

The primary outcome was not going home after treatment for AHF. In the primary analysis, we included in-hospital death in the outcome. We performed an analysis stratified by age, sex, and Barthel index. The cutoff of age and Barthel index category division, was 80 years and 60, respectively, either of which was the median value among the whole population.

Statistical analysis

Patient characteristics

We summarized the patients’ demographics based on the site of discharge. Patient characteristics were compared across the places of discharge using the chi-squared test or the Wilcoxon rank-sum test.

Identifying risk factors and developing a prediction model

We classified the included patients into a training set consisting of randomly selected 80% and a test set using the remaining 20% of the total patients.
To create a model that has both a better discrimination ability and a clinical usability, we used binomial logistic models with L1-penalized estimation (least absolute shrinkage and selection operator, Lasso regression). Considering the trade-off between explainability versus complexity among machine learning methods, the Lasso regression focuses on explainability and facilitates interpretation of the prepared model by performing variable selection via shrinkage of the coefficients of some noninformative variables to 0 [15]. Regarding Lasso regression, we used one standard error (1SE) rule to achieve more parsimonious models; 1-SE rule of Lasso regression was described in details and used to make parsimonious models recently [16]. Briefly, ordinary Lasso regression is a machine learning that uses the optimal value for the hyperparameter λ to maximize the frequency of correct categorization with tenfold inner cross-validation, and 1SE rule utilizes the maximal λ within 1SE of the difference. Candidate variables are all available variables that are considered important in this study of AHF.
We compared two models in terms of discrimination ability and calibration ability: one using 1SE-selected variables and the other using all the 26 variables.

Model validation

We evaluated the model in terms of discriminative ability and calibration in the test set (the remaining 20% of the sample). Regarding discriminative ability evaluation, we measured the predictive performance using c-statistics (area under the receiver operating characteristic curve). The c-statistic was described with its 95% confidence intervals (CI). We showed c-statistic in each selected variable and its stepwise change based on the variable importance prepared by the machine learning. To assess the calibration of the prepared model, we used “pmcalplot” in Stata to describe from the calibration curve the following components: calibration in the large (CITL) index, showing the difference between the average predicted probabilities and the observed event frequencies, whose ideal value should be zero; (ii) the calibration slope, whose ideal value should be one; and (iii) the expected probability vs observed frequency (E:O) ratio, whose ideal value should be one as used in several previous studies [1719].

Sensitivity analyses

We conducted three sensitivity analyses for the primary outcome. First, we prepared the predictive model after changing the time window for observing procedures or drug administration from the first 2 days to the first 3 days of hospitalization to confirm that the window period (2 days) was not arbitrary and that the gained information was robust. Next, as another sensitivity analysis, we regarded patients with length of stay ≥ 30 days as patients undergoing non-home discharge, because hospital stay this long may have been due to the inability of the family members or caregivers to bring the patient home smoothly, which may equal to non-home discharge. Finally, we excluded those undergoing in-hospital death, and performed the analysis, because discharge dead may differ in character from non-home discharge alive. We performed all statistical analyses by use of Stata Version 17 (StataCorp, College Station, TX, USA), and used a two-tailed significance level of P < 0.05. Part of the Stata script used in this study is stored as Supplementary Fig. 1.
Patient and public involvement statement
Patients were not involved in the design, or conduct, or reporting, or dissemination plans of our research.

Results

Study population

We present the patient selection flowchart as Fig. 1. Among all the eligible patients in the DPC database from April 2014 to March 2018, we identified 170,007 patients undergoing an unscheduled admission for treatment of AHF with NYHA grade ≥ II; a total of 41,939 patients were excluded (Fig. 1).
The 128,068 eligible patients hospitalized for AHF in 817 hospitals were analyzed. Overall, 22,330 (17.4%) patients underwent in-hospital death (n = 7,879) or non-home discharge, that is, transferred to other facilities (n = 14,451) such as nursery home, after treatment of AHF (Table 1). Those who could not go home after treatment for AHF were more likely to be older, female, lean, have consciousness disturbance, more severe AHF, history of readmission for heart failure within previous 30 days, such comorbidities as kidney failure, ischemic heart disease, or cancer, and undergo such procedures as transfusion for anemia or intensive therapy related to AHF treatment.
Table 1
Characteristics of eligible patients
Variable
Category
Home discharge
Non-home discharge or in-hospital death
p-value
  
n = 105,738
n = 22,330
 
Age
 
80.0 (71.0–86.0)
85.0 (79.0–89.0)
 < 0.001
Age category
 < 65 years
14,894 (14.1%)
1,240 (5.6%)
 < 0.001
 
65–74 years
21,146 (20.0%)
2,425 (10.9%)
 
 
75–84 years
38,081 (36.0%)
7,202 (32.3%)
 
 
85– years
31,617 (29.9%)
11,463 (51.3%)
 
Male
 
60,349 (57.1%)
10,880 (48.7%)
 < 0.001
Body mass index (kg/m2)
 
22.5 (20.0–25.4)
21.1 (18.7–23.8)
 < 0.001
Body mass index category
–18.49 kg/m2
14,443 (13.7%)
5,297 (23.7%)
 < 0.001
18.5–24.99 kg/m2
62,040 (58.7%)
13,076 (58.6%)
 
25.00 kg/m2
29,255 (27.7%)
3,957 (17.7%)
 
Barthel index
 
70 (25–100)
20 (0–65)
 < 0.001
Consciousness on admission
Alert
94,315 (89.2%)
16,376 (73.3%)
 < 0.001
Impaired
11,423 (10.8%)
5,954 (26.7%)
 
Categorization based on New York Heart Association
Class II
31,310 (29.6%)
4,193 (18.8%)
 < 0.001
Class III
41,561 (39.3%)
7,860 (35.2%)
 
Class IV
32,867 (31.1%)
10,277 (46.0%)
 
Admission on weekends or holidays
22,821 (21.6%)
5,480 (24.5%)
 < 0.001
With readmission history for heart failure within previous 30 days
7,481 (7.1%)
1,834 (8.2%)
 < 0.001
Hypertension
 
61,613 (58.3%)
9,341 (41.8%)
 < 0.001
Diabetes mellitus
 
31,215 (29.5%)
5,424 (24.3%)
 < 0.001
Kidney failure or kidney replacement therapy receipt within 2 days
13,233 (12.5%)
3,907 (17.5%)
 < 0.001
Liver disease
 
2,435 (2.3%)
499 (2.2%)
0.54
Pulmonary disease
 
8,056 (7.6%)
1,601 (7.2%)
0.021
Ischemic heart disease
 
1,231 (1.2%)
495 (2.2%)
 < 0.001
Cancer
 
4,752 (4.5%)
1,143 (5.1%)
 < 0.001
Dilated cardiomyopathy
 
5,256 (5.0%)
809 (3.6%)
 < 0.001
Shock or ventricular fibrillation on admission
1,028 (1.0%)
558 (2.5%)
 < 0.001
Osteoporosis
 
2,009 (1.9%)
356 (1.6%)
0.002
Charlson comorbidity index
0.0 (0.0–1.0)
0.0 (0.0–2.0)
 < 0.001
Anemia on admission or transfusion within 2 days
8,490 (8.0%)
2,345 (10.5%)
 < 0.001
Intensive cardiopulmonary support within 2 days
 
14,756 (14.0%)
4,208 (18.8%)
 < 0.001
Intravenous loop diuretics within 2 days
73,336 (69.4%)
15,932 (71.3%)
 < 0.001
Intravenous vasopressors within 2 days
14,810 (14.0%)
5,141 (23.0%)
 < 0.001
Intensive care unit use within 2 days
17,420 (16.5%)
4,640 (20.8%)
 < 0.001
Enteral alimentation within 2 days
95,161 (90.0%)
17,523 (78.5%)
 < 0.001
Rehabilitation within 2 days
 
12,251 (11.6%)
2,533 (11.3%)
0.30
Data are presented as median (interquartile range) for continuous measures, and n (%) for categorical measures

Determination of factors related to the failure to return home alive after hospitalization

We first divided the whole population into the training set (80%) and the test set (20%) (Supplementary Table 1). The process of variable selection using the 1SE rule of Lasso regression is shown in Fig. 2. We selected the value of hyperparameter λ in the following fashion: after determining λCV, where the cross-validation function resulted in the minimized value, we found λSE, which is the largest λ while being within the 1SE of the lowest mean squared error. Thus, from the 1SE rule of Lasso regression, we constructed the model using variables selected by Lasso regression (model using 1SE-selected variables) to predict non-home discharge, and with use of this λSE, 11 variables were selected, and the variable importance generated via machine learning is shown in Fig. 2B. The most important factor for the prediction of the non-home discharge was a lower Barthel index on admission (odds ratio, 1.12 per 10 points decrease; 95% CI 1.11–1.12), followed by higher age (odds ratio, 1.49 per 10-year increase; 95% CI 1.46–1.52), the absence of comorbid hypertension, the impaired consciousness on admission, the use of vasopressors, the highest NYHA class (Fig. 3). The coefficients of regression using the variables selected by the 1SE rule is shown in Table 2. In the model using all the 26 variables, the coefficients of the multivariable regression are shown in Supplementary Table 2.
Table 2
Odds ratios of the variables selected by 1 standard-error rule of Lasso regression in predicting non-home discharge or in-hospital death
Variable
Category
Odds ratio
95% confidence interval
P value
Age (10-year increase)
1.49
1.46–1.52
 < 0.001
Body mass index (5-kg/m2 decrease)
1.20
1.18–1.23
 < 0.001
Barthel index (10-point decrease)
1.12
1.11–1.12
 < 0.001
Consciousness on admission
Alert
Reference
  
 
Impaired
1.58
1.51–1.65
 < 0.001
Categorization based on New York Heart Association
Class II
Reference
  
 
Class III
1.26
1.20–1.32
 < 0.001
 
Class IV
1.63
1.56–1.71
 < 0.001
Absence of comorbid hypertension
1.79
1.73–1.86
 < 0.001
Kidney failure or kidney replacement therapy receipt within 2 days
1.28
1.22–1.34
 < 0.001
Charlson comorbidity index
1.07
1.05–1.08
 < 0.001
Shock or ventricular fibrillation on admission
1.50
1.32–1.71
 < 0.001
Intravenous vasopressors within 2 days
1.57
1.50–1.64
 < 0.001
Failure to initiate enteral alimentation within 2 days
1.52
1.45–1.60
 < 0.001

Model validation in terms of predictive ability and calibration of the developed models

The model using 11 variables selected by 1SE rule of Lasso regression had a comparable discrimination ability with the model using all the 26 variables (c-statistic: 0.760 [95% CI 0.752–0.767] vs. 0.761 [95% CI 0.753–0.768], respectively) (Fig. 4A). The c-statistic of the model using each variable ordered by the variable importance, and c-statistic of the model as one single variable was added are shown in Supplementary Table 3. Analysis of calibration of both models showed that both models had a good calibration with an E:O ratio of 0.974, CITL value of 0.037, and slope of 1.036 in the model using the variables selected by 1SE of Lasso regression, and with an E:O ratio of 0.973, CITL value of 0.038, and slope of 1.035 in the model using all variables (Fig. 4B).

Stratified analyses

When stratified by age and sex, the results were similar to those of the primary analysis. Among those aged ≥ 80 years (n = 69,168), 16,164 (23.4%) underwent transferal to another facility or in-hospital death, while among those aged < 80 years (n = 58,900), 6,166 (10.5%) underwent in-hospital death or non-home discharge. The age-stratified analyses selected the same predictors in the 1SE rule of Lasso regression completely although the order of the variable importance differed (Supplementary Figs. 2 and 3). The selected variables were Barthel index decrease, age increase, absence of comorbid hypertension, vasopressor use, impaired consciousness, worst NYHA class, BMI decrease, failure to initiate enteral alimentation, and kidney failure or kidney replacement therapy receipt within 2 days. Supplementary Figs. 4 and 5 show the discrimination ability and calibration for each group, and the results were similar to those of the main analysis. The odds ratios in the model using 1SE-selected variables are shown in Supplementary Tables 4 and 5.
Among female patients (n = 56,839), 11,450 (20.1%) underwent transferal to another facility or in-hospital death; while among male patients (n = 71,229), 10,880 (15.3%) underwent in-hospital death or non-home discharge. The sex-stratified analyses also yielded a similar pattern of variable importance in the Lasso regression model (Supplementary Figs. 6 and 7). Commonly selected variables were Barthel index decrease, absence of comorbid hypertension, vasopressor use, impaired consciousness, worst NYHA class, BMI decrease, failure to initiate enteral alimentation, kidney failure, and age increase. Supplementary Figs. 8 and 9 show the receiver operating characteristic curve and calibration curves for each group, respectively, and the results were similar to those of the main analysis. The odds ratios in the model using 1SE-selected variables are shown in Supplementary Tables 6 and 7.
Similarly, among patients with Barthel index ≥ 60 and Barthel index < 60, the results were similar. While patients with Barthel index ≥ 60 (n = 66,301), 6329 (9.5%) underwent transferal to another facility or in-hospital death, among patients with Barthel index < 60 (n = 61,767) 16,001 (25.9%) underwent in-hospital death or non-home discharge. Figures for variable importance, discriminative ability and calibration in the Lasso regression model are shown in Supplementary Figs. 10–13. Commonly selected variables were Barthel index decrease, absence of comorbid hypertension, vasopressor use, impaired consciousness, worst NYHA class, BMI decrease, failure to initiate enteral alimentation, and age increase. The odds ratios in the model using 1SE-selected variables are shown in Supplementary Tables 8 and 9.

Sensitivity analyses

When changing the time window to 2 days to 3 days, a total of 126,923 patients with 21,871 (17.2%) reaching the outcome were analyzed (Supplementary Fig. 14). Supplementary Fig. 15 shows the importance of variables in predicting non-home discharge, and nine variables were selected; and c-statistics were comparable (model using 1SE-selected variables: 0.759 (95% CI 0.751–0.767) vs model using all variables: 0.761 (95% CI 0.754–0.769)). Analysis of calibration of both models revealed that both models had a comparable calibration ability with an E:O ratio of 0.985, CITL value of 0.021, and slope of 1.030 in the model using variables selected by 1SE rule of Lasso regression, and with an E:O ratio of 0.985, CITL value of 0.021, and slope of 1.032 in the model using all variables (Supplementary Fig. 16). The odds ratios in the model using 1SE-selected variables are shown in Supplementary Table 10.
After recategorizing patients with length of stay ≥ 30 days into those undergoing non-home discharge as the second sensitivity analysis, 39,332 (30.7%) reached the outcome. The importance of variables in predicting non-home discharge in this sensitivity analysis is shown in Supplementary Fig. 17. In the model, 17 variables were selected, the variables added to those selected in the primary analysis were female, anemia, failure to initiate rehabilitation within 2 days, readmission history, admission on weekends or holidays, and ischemic heart disease; c-statistics were comparable (model using 1SE-selected variables: 0.702 (95% CI, 0.695–0.709) vs model using all variables: 0.702 (95% CI, 0.696–0.709)). Both models had a comparable calibration (Supplementary Fig. 18B). The odds ratios in the model using 1SE-selected variables are shown in Supplementary Table 11.
Finally, after exclusion of those undergoing in-hospital death (n = 7879), 14,451 (12.0%) did not return home after hospitalization out of the total 120,189 patients. Supplementary Fig. 19 shows the importance of variables in predicting non-home discharge in this case scenario. In the model, six variables were selected, and c-statistics were comparable (model using 1SE-selected variables: 0.733 (95% CI, 0.724–0.743) vs model using all variables: 0.740 (95% CI, 0.730–0.749)). Both models had a comparable calibration (Supplementary Fig. 20B). The odds ratios in the model using 1SE-selected variables are shown in Supplementary Table 12.

Discussion

The present study using a nationwide inpatient database including 128,068 patients hospitalized for AHF, we succeeded in developing a parsimonious and easy-to-grasp model via machine learning, and the model using 11 variables selected by the 1SE rule of Lasso regression presented a discriminative ability and calibration comparable to the model using all the 26 variables to predict non-home discharge. The essential determinants associated with non-home discharge, which were selected consistently throughout all the analyses, were low scores in Barthel index, advanced age, absence of comorbid hypertension, impaired consciousness, failure to initiate enteral alimentation within 2 days and low body weight.
There have been so far only few studies focusing on discharge disposition in patients hospitalized for AHF [2024]. Our analysis showed that approximately 80% of study population discharged to home. This percentage was in agreement with a result of a multicenter registry including 4056 patients hospitalized for AHF in Japan, demonstrating the non-home discharge rate of 13.0% [24]. In the prospective study and our study, higher ages, lower BMI are commonly identified as predictive factors for non-home discharge [24]. Our study, although using the retrospective design, had novelty in showing the variable importance of each predictive marker via machine learning usage and yielding statistical significance on variables such as kidney failure probably due to the large sample size of our cohort. On the other hand, non-home discharge rate was much lower than that previously reported in U.S. For example, the recent analysis using the Get With The Guidelines-Heart Failure registry showed that the proportion of patients discharged to home was approximately 75% [22]. We suppose that this difference largely attributed to the difference in medical care system and length of hospital stay between countries. In this study, the median length of hospital stay was 12 days, whereas 4 days in U.S. [2, 22]. Longer hospital stay of AHF patients in Japan would contribute to the low non-home discharge rate.
Factors identified as predictors of non-home discharge are mostly pathophysiologically plausible. Barthel Index is an established indicator for activities of daily living, and our results including a multitude of sensitivity analyses demonstrated that lower Barthel Index was consistently the strongest predictor of non-home discharge. Given that poor activities of daily living were reported to be associated with adverse clinical outcomes of AHF patients [25], our results are reasonable. As expected, older age also strongly predicted non-home discharge. Older HF patients were increasing in developed countries including Japan [11]. For example, we previously reported that the proportion of hospitalized AHF patients aged ≥ 80 years and those aged ≥ 90 years in Japan reached 54.3% and 14.4%, respectively [11]. Given this background, older AHF patients at high risk for non-home discharge are expected to increase further. It is indispensable to establish regional health care system and network for older AHF patients who could not be discharged home. Low BMI was associated with an elevated risk for non-home discharge. Given that low Barthel Index, older age, and low BMI all increased the risk of non-home discharge, we may need to consider the potential role of malnutrition, frailty, or sarcopenia which would frequently coexist with these clinical characteristics in patients with AHF, for non-home discharge. It is also essential that the factors reflecting the severity at the hospital admission (e.g., advanced HF symptom [higher NYHA class], conscious disturbance, unstable hemodynamic state [requiring inotropic agent]) were identified as predictors for non-home discharge, which emphasized the clinical importance of early detection of worsening HF and timely treatment. Interestingly, we found that early enteral alimentation would decrease the possibility of non-home discharge, which was in line with our previous study [26]. Physicians may need to start the enteral alimentation for hospitalized patients with AHF as early as possible after the hospital admission in possible cases. At least, we should avoid delaying the initiation of feeding without a solid reason. Absence of comorbid hypertension was also a positive predictor of non-home discharge; this was plausible because results of previous studies [27, 28] showed that patients admitted for AHF with preserved or high blood pressure have generally a better prognosis than those with low blood pressure.
We applied a type of machine learning, Lasso regression, that stresses inference rather than prediction. Generally speaking, which machine learning method to choose in clinical epidemiology depends on the trade-off between interpretability versus complexity [15]. The trade-off means that the higher complexity a machine learning has, the lower interpretability but higher predictive ability it has while the lower complexity a machine learning has, the higher interpretability but lower predictive ability it has [15]. Lasso regression shrinks the coefficients of some noninformative variables to 0, and enhances the interpretability of the prepared model via this variable reduction; thus, Lasso regression is applied when researchers want to stress interpretability at the cost of predictive ability. Further, to strengthen variable shrinkage, we applied 1-SE rule of the lasso regression, which enabled identification of essential variables for the outcome of our study.
The present study has clinical implications. Our study showed that we could predict the discharge disposition of hospitalized patients owing to AHF with a high accuracy using the clinical information within 2 days after hospital admission which was generally included in an administrative claims database. For patients who are expected to have difficulty in being discharged home according to this prediction model, coordination of a medical facility where a patient would be transferred after the acute care for AHF should be started early in the hospitalization process to reduce the burden on healthcare professionals, patients, and their families, and to enable smooth healthcare coordination in a community. Furthermore, we created a simple model, whereby clinicians can easily apply to real-world clinical practice.
We acknowledge several limitations to the present study. The possibility of unmeasured residual confounding could not be eliminated. For example, the presence of family caregivers would influence the discharge disposition. Further, we could not utilize and adjust for not only biomarkers such as blood pressure, BNP, electrolytes, hemoglobin, or serum creatinine but also data on etiology of HF or echocardiographic parameters such as left ventricular ejection fraction. Unfortunately, these data were unavailable in our DPC database. Although the validity of diagnoses and procedures in this database was reported to be high in Japan [29, 30], the recorded diagnoses of might have been misclassified. Healthcare system and regional factors could affect the study results. For example, Japan has the universal healthcare insurance system and patients could always get medical service with relatively low cost. Therefore, although this study used a nationwide large-scale inpatient dataset, our results cannot be generalized to other countries. Especially, validation of our predictive model needs conducting with use of different databases in different countries or settings. Further investigations using other independent datasets are required to validate our result.

Conclusions

Our analysis of a nationwide inpatient database demonstrated that approximately 80% of hospitalized AHF patients discharged to home, whereas the remaining 20% of patients underwent in-hospital death or discharged to other facilities including other medical institutes and nursing homes. We developed a machine learning-based prediction model, and low scores in activities of daily living, advanced age, absence of comorbid hypertension, impaired consciousness, failure to initiate enteral alimentation within 2 days and low body weight were strong determinants of non-home discharge among hospitalized patients for AHF. We believe that results of the present study could provide practical data to build up the optimal medical care system and network for HF patients in the era when patients with HF are rapidly increasing worldwide.

Declarations

Conflict of interest

The authors declare that there are no relationships or activities that might bias, or be perceived to bias, their work.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​.

Unsere Produktempfehlungen

Neuer Inhalt

Print-Titel

e.Med Interdisziplinär

Kombi-Abonnement

Jetzt e.Med zum Sonderpreis bestellen!

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

Jetzt bestellen und 100 € sparen!

Anhänge

Supplementary Information

Below is the link to the electronic supplementary material.
Literatur
1.
Zurück zum Zitat Savarese G, Becher PM, Lund LH et al (2023) Global burden of heart failure: a comprehensive and updated review of epidemiology. Cardiovasc Res 118:3272–3287CrossRefPubMed Savarese G, Becher PM, Lund LH et al (2023) Global burden of heart failure: a comprehensive and updated review of epidemiology. Cardiovasc Res 118:3272–3287CrossRefPubMed
2.
Zurück zum Zitat Ambrosy AP, Fonarow GC, Butler J et al (2014) The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries. J Am Coll Cardiol 63:1123–1133CrossRefPubMed Ambrosy AP, Fonarow GC, Butler J et al (2014) The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries. J Am Coll Cardiol 63:1123–1133CrossRefPubMed
3.
Zurück zum Zitat Lloyd-Jones DM, Larson MG, Leip EP et al (2002) Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation 106:3068–3072CrossRefPubMed Lloyd-Jones DM, Larson MG, Leip EP et al (2002) Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation 106:3068–3072CrossRefPubMed
4.
Zurück zum Zitat Shimokawa H, Miura M, Nochioka K et al (2015) Heart failure as a general pandemic in Asia. Eur J Heart Fail 17:884–892CrossRefPubMed Shimokawa H, Miura M, Nochioka K et al (2015) Heart failure as a general pandemic in Asia. Eur J Heart Fail 17:884–892CrossRefPubMed
6.
7.
8.
Zurück zum Zitat Okura Y, Ramadan MM, Ohno Y et al (2008) Impending epidemic: future projection of heart failure in Japan to the year 2055. Circ J 72:489–491CrossRefPubMed Okura Y, Ramadan MM, Ohno Y et al (2008) Impending epidemic: future projection of heart failure in Japan to the year 2055. Circ J 72:489–491CrossRefPubMed
9.
Zurück zum Zitat Yasuda S, Miyamoto Y, Ogawa H (2018) Current status of cardiovascular medicine in the aging society of Japan. Circulation 138:965–967CrossRefPubMed Yasuda S, Miyamoto Y, Ogawa H (2018) Current status of cardiovascular medicine in the aging society of Japan. Circulation 138:965–967CrossRefPubMed
10.
Zurück zum Zitat Komuro I, Kaneko H, Morita H et al (2019) Nationwide actions against heart failure pandemic in Japan—what should we do from academia? Circ J 83:1819–1821CrossRefPubMed Komuro I, Kaneko H, Morita H et al (2019) Nationwide actions against heart failure pandemic in Japan—what should we do from academia? Circ J 83:1819–1821CrossRefPubMed
11.
Zurück zum Zitat Kaneko H, Itoh H, Yotsumoto H et al (2020) Characteristics and outcomes of super-elderly patients (aged>=90 years) hospitalized for heart failure—analysis of a nationwide inpatient database. Circ Rep 2:393–399CrossRefPubMedPubMedCentral Kaneko H, Itoh H, Yotsumoto H et al (2020) Characteristics and outcomes of super-elderly patients (aged>=90 years) hospitalized for heart failure—analysis of a nationwide inpatient database. Circ Rep 2:393–399CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Itoh H, Kaneko H, Kiriyama H et al (2021) Reverse J-shaped relationship between body mass index and in-hospital mortality of patients hospitalized for heart failure in Japan. Heart Vessels 36:383–392CrossRefPubMed Itoh H, Kaneko H, Kiriyama H et al (2021) Reverse J-shaped relationship between body mass index and in-hospital mortality of patients hospitalized for heart failure in Japan. Heart Vessels 36:383–392CrossRefPubMed
13.
Zurück zum Zitat Quan H, Li B, Couris CM et al (2011) Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol 173:676–682CrossRefPubMed Quan H, Li B, Couris CM et al (2011) Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol 173:676–682CrossRefPubMed
14.
Zurück zum Zitat Kaneko H, Itoh H, Yotsumoto H et al (2020) Association of cancer with outcomes in patients hospitalized for heart failure. Circ J 84:1771–1778CrossRefPubMed Kaneko H, Itoh H, Yotsumoto H et al (2020) Association of cancer with outcomes in patients hospitalized for heart failure. Circ J 84:1771–1778CrossRefPubMed
15.
Zurück zum Zitat Leist AK, Klee M, Kim JH et al (2022) Mapping of machine learning approaches for description, prediction, and causal inference in the social and health sciences. Sci Adv 8:1942CrossRef Leist AK, Klee M, Kim JH et al (2022) Mapping of machine learning approaches for description, prediction, and causal inference in the social and health sciences. Sci Adv 8:1942CrossRef
16.
Zurück zum Zitat Okada A, Hashimoto Y, Goto T et al (2022) A machine learning-based predictive model to identify patients who failed to attend a follow-up visit for diabetes care after recommendations from a national screening program. Diabetes Care Okada A, Hashimoto Y, Goto T et al (2022) A machine learning-based predictive model to identify patients who failed to attend a follow-up visit for diabetes care after recommendations from a national screening program. Diabetes Care
17.
Zurück zum Zitat Moledina SM, Kontopantelis E, Wijeysundera HC et al (2022) Ethnicity-dependent performance of the Global Registry of Acute Coronary Events risk score for prediction of non-ST-segment elevation myocardial infarction in-hospital mortality: nationwide cohort study. Eur Heart J Moledina SM, Kontopantelis E, Wijeysundera HC et al (2022) Ethnicity-dependent performance of the Global Registry of Acute Coronary Events risk score for prediction of non-ST-segment elevation myocardial infarction in-hospital mortality: nationwide cohort study. Eur Heart J
18.
Zurück zum Zitat Agnes A, Biondi A, Persiani R et al (2022) Development of the PERI-Gastric (PEritoneal Recurrence Index) and PERI-Gram (Peritoneal Recurrence Index NomoGRAM) for predicting the risk of metachronous peritoneal carcinomatosis after gastrectomy with curative intent for gastric cancer. Gastr Cancer 25:629–639CrossRef Agnes A, Biondi A, Persiani R et al (2022) Development of the PERI-Gastric (PEritoneal Recurrence Index) and PERI-Gram (Peritoneal Recurrence Index NomoGRAM) for predicting the risk of metachronous peritoneal carcinomatosis after gastrectomy with curative intent for gastric cancer. Gastr Cancer 25:629–639CrossRef
19.
Zurück zum Zitat Llueca A, Climent MT, Escrig J et al (2021) Validation of three predictive models for suboptimal cytoreductive surgery in advanced ovarian cancer. Sci Rep 11:8111CrossRefPubMedPubMedCentral Llueca A, Climent MT, Escrig J et al (2021) Validation of three predictive models for suboptimal cytoreductive surgery in advanced ovarian cancer. Sci Rep 11:8111CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Hauptman PJ, Goodlin SJ, Lopatin M et al (2007) Characteristics of patients hospitalized with acute decompensated heart failure who are referred for hospice care. Arch Intern Med 167:1990–1997CrossRefPubMed Hauptman PJ, Goodlin SJ, Lopatin M et al (2007) Characteristics of patients hospitalized with acute decompensated heart failure who are referred for hospice care. Arch Intern Med 167:1990–1997CrossRefPubMed
21.
Zurück zum Zitat Akintoye E, Briasoulis A, Egbe A et al (2017) Regional variation in mortality, length of stay, cost, and discharge disposition among patients admitted for heart failure in the United States. Am J Cardiol 120:817–824CrossRefPubMed Akintoye E, Briasoulis A, Egbe A et al (2017) Regional variation in mortality, length of stay, cost, and discharge disposition among patients admitted for heart failure in the United States. Am J Cardiol 120:817–824CrossRefPubMed
22.
Zurück zum Zitat Fleming LM, Zhao X, DeVore AD et al (2018) Early ambulation among hospitalized heart failure patients is associated with reduced length of stay and 30-day readmissions. Circ Heart Fail 11:e004634CrossRefPubMed Fleming LM, Zhao X, DeVore AD et al (2018) Early ambulation among hospitalized heart failure patients is associated with reduced length of stay and 30-day readmissions. Circ Heart Fail 11:e004634CrossRefPubMed
23.
Zurück zum Zitat Eastwood CA, Howlett JG, King-Shier KM et al (2014) Determinants of early readmission after hospitalization for heart failure. Can J Cardiol 30:612–618CrossRefPubMed Eastwood CA, Howlett JG, King-Shier KM et al (2014) Determinants of early readmission after hospitalization for heart failure. Can J Cardiol 30:612–618CrossRefPubMed
24.
Zurück zum Zitat Washida K, Kato T, Ozasa N et al (2021) Risk factors and clinical outcomes of nonhome discharge in patients with acute decompensated heart failure: an observational study. J Am Heart Assoc 10:e020292CrossRefPubMedPubMedCentral Washida K, Kato T, Ozasa N et al (2021) Risk factors and clinical outcomes of nonhome discharge in patients with acute decompensated heart failure: an observational study. J Am Heart Assoc 10:e020292CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Katano S, Yano T, Ohori K et al (2021) Barthel index score predicts mortality in elderly heart failure—a goal of comprehensive cardiac rehabilitation. Circ J 86:70–78CrossRefPubMed Katano S, Yano T, Ohori K et al (2021) Barthel index score predicts mortality in elderly heart failure—a goal of comprehensive cardiac rehabilitation. Circ J 86:70–78CrossRefPubMed
26.
Zurück zum Zitat Kaneko H, Itoh H, Morita K et al (2021) Early initiation of feeding and in-hospital outcomes in patients hospitalized for acute heart failure. Am J Cardiol 145:85–90CrossRefPubMed Kaneko H, Itoh H, Morita K et al (2021) Early initiation of feeding and in-hospital outcomes in patients hospitalized for acute heart failure. Am J Cardiol 145:85–90CrossRefPubMed
27.
Zurück zum Zitat Domanski MJ, Mitchell GF, Norman JE et al (1999) Independent prognostic information provided by sphygmomanometrically determined pulse pressure and mean arterial pressure in patients with left ventricular dysfunction. J Am Coll Cardiol 33:951–958CrossRefPubMed Domanski MJ, Mitchell GF, Norman JE et al (1999) Independent prognostic information provided by sphygmomanometrically determined pulse pressure and mean arterial pressure in patients with left ventricular dysfunction. J Am Coll Cardiol 33:951–958CrossRefPubMed
28.
Zurück zum Zitat Youn JC, Han S, Ryu KH (2017) Temporal trends of hospitalized patients with heart failure in Korea. Korean Circ J 47:16–24CrossRefPubMed Youn JC, Han S, Ryu KH (2017) Temporal trends of hospitalized patients with heart failure in Korea. Korean Circ J 47:16–24CrossRefPubMed
29.
Zurück zum Zitat Yamana H, Moriwaki M, Horiguchi H et al (2017) Validity of diagnoses, procedures, and laboratory data in Japanese administrative data. J Epidemiol 27:476–482CrossRefPubMedPubMedCentral Yamana H, Moriwaki M, Horiguchi H et al (2017) Validity of diagnoses, procedures, and laboratory data in Japanese administrative data. J Epidemiol 27:476–482CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Fujihara K, Yamada-Harada M, Matsubayashi Y et al (2021) Accuracy of Japanese claims data in identifying diabetes-related complications. Pharmacoepidemiol Drug Saf 30:594–601CrossRefPubMed Fujihara K, Yamada-Harada M, Matsubayashi Y et al (2021) Accuracy of Japanese claims data in identifying diabetes-related complications. Pharmacoepidemiol Drug Saf 30:594–601CrossRefPubMed
Metadaten
Titel
A machine-learning-based prediction of non-home discharge among acute heart failure patients
verfasst von
Akira Okada
Hidehiro Kaneko
Masaaki Konishi
Kentaro Kamiya
Tadafumi Sugimoto
Satoshi Matsuoka
Isao Yokota
Yuta Suzuki
Satoko Yamaguchi
Hidetaka Itoh
Katsuhito Fujiu
Nobuaki Michihata
Taisuke Jo
Hiroki Matsui
Kiyohide Fushimi
Norifumi Takeda
Hiroyuki Morita
Hideo Yasunaga
Issei Komuro
Publikationsdatum
03.05.2023
Verlag
Springer Berlin Heidelberg
Erschienen in
Clinical Research in Cardiology / Ausgabe 4/2024
Print ISSN: 1861-0684
Elektronische ISSN: 1861-0692
DOI
https://doi.org/10.1007/s00392-023-02209-0

Weitere Artikel der Ausgabe 4/2024

Clinical Research in Cardiology 4/2024 Zur Ausgabe

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

21.05.2024 TAVI Nachrichten

Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.